Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles.

Ciesek S, Westhaus S, Wicht M, Wappler I, Henschen S, Sarrazin C, Hamdi N, Abdelaziz AI, Strassburg CP, Wedemeyer H, Manns MP, Pietschmann T, von Hahn T.

J Virol. 2011 Aug;85(15):7613-21. doi: 10.1128/JVI.00212-11. Epub 2011 Jun 1.

2.

Species-specific regions of occludin required by hepatitis C virus for cell entry.

Michta ML, Hopcraft SE, Narbus CM, Kratovac Z, Israelow B, Sourisseau M, Evans MJ.

J Virol. 2010 Nov;84(22):11696-708. doi: 10.1128/JVI.01555-10. Epub 2010 Sep 15.

3.

The second extracellular loop dictates Occludin-mediated HCV entry.

Liu S, Kuo W, Yang W, Liu W, Gibson GA, Dorko K, Watkins SC, Strom SC, Wang T.

Virology. 2010 Nov 10;407(1):160-70. doi: 10.1016/j.virol.2010.08.009. Epub 2010 Sep 6.

4.

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.

Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM.

Nature. 2009 Feb 12;457(7231):882-6. doi: 10.1038/nature07684. Epub 2009 Jan 28.

5.

Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.

Sourisseau M, Michta ML, Zony C, Israelow B, Hopcraft SE, Narbus CM, Parra Martín A, Evans MJ.

PLoS Pathog. 2013 Mar;9(3):e1003244. doi: 10.1371/journal.ppat.1003244. Epub 2013 Mar 21.

6.

Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.

Fénéant L, Ghosn J, Fouquet B, Helle F, Belouzard S, Vausselin T, Séron K, Delfraissy JF, Dubuisson J, Misrahi M, Cocquerel L.

PLoS One. 2015 Nov 12;10(11):e0142539. doi: 10.1371/journal.pone.0142539. eCollection 2015.

7.

Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.

Ding Q, von Schaewen M, Hrebikova G, Heller B, Sandmann L, Plaas M, Ploss A.

J Virol. 2017 Jan 31;91(4). pii: e01799-16. doi: 10.1128/JVI.01799-16. Print 2017 Feb 15.

8.

Two methods of heterokaryon formation to discover HCV restriction factors.

Frentzen A, Hueging K, Bitzegeio J, Pietschmann T, Steinmann E.

J Vis Exp. 2012 Jul 16;(65):e4029. doi: 10.3791/4029.

9.

The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.

Benedicto I, Molina-Jiménez F, Bartosch B, Cosset FL, Lavillette D, Prieto J, Moreno-Otero R, Valenzuela-Fernández A, Aldabe R, López-Cabrera M, Majano PL.

J Virol. 2009 Aug;83(16):8012-20. doi: 10.1128/JVI.00038-09. Epub 2009 Jun 10.

10.

Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line.

Haid S, Windisch MP, Bartenschlager R, Pietschmann T.

J Virol. 2010 Jan;84(2):964-75. doi: 10.1128/JVI.01504-09. Epub 2009 Nov 4.

11.

Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection.

Shirasago Y, Shimizu Y, Tanida I, Suzuki T, Suzuki R, Sugiyama K, Wakita T, Hanada K, Yagi K, Kondoh M, Fukasawa M.

Biol Pharm Bull. 2016 May 1;39(5):839-48. doi: 10.1248/bpb.b15-01023. Epub 2016 Feb 17.

12.

Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry.

Kohaar I, Ploss A, Korol E, Mu K, Schoggins JW, O'Brien TR, Rice CM, Prokunina-Olsson L.

J Virol. 2010 Jul;84(14):6987-94. doi: 10.1128/JVI.00196-10. Epub 2010 May 12.

13.

MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA.

Sendi H, Mehrab-Mohseni M, Foureau DM, Ghosh S, Walling TL, Steuerwald N, Zamor PJ, Kaplan KJ, Jacobs C, Ahrens WA, Russo MW, Clemens MG, Schrum LW, Bonkovsky HL.

Liver Int. 2015 Apr;35(4):1315-23. doi: 10.1111/liv.12698. Epub 2014 Oct 28.

PMID:
25302477
14.

Completion of the entire hepatitis C virus life cycle in genetically humanized mice.

Dorner M, Horwitz JA, Donovan BM, Labitt RN, Budell WC, Friling T, Vogt A, Catanese MT, Satoh T, Kawai T, Akira S, Law M, Rice CM, Ploss A.

Nature. 2013 Sep 12;501(7466):237-41. doi: 10.1038/nature12427. Epub 2013 Jul 31.

15.

Mouse hepatic cells support assembly of infectious hepatitis C virus particles.

Long G, Hiet MS, Windisch MP, Lee JY, Lohmann V, Bartenschlager R.

Gastroenterology. 2011 Sep;141(3):1057-66. doi: 10.1053/j.gastro.2011.06.010. Epub 2011 Jun 13.

PMID:
21699799
16.

Differential expression of candidate virus receptors in human T lymphocytes prone or resistant to infection with patient-derived hepatitis C virus.

Sarhan MA, Chen AY, Michalak TI.

PLoS One. 2013 Apr 23;8(4):e62159. doi: 10.1371/journal.pone.0062159. Print 2013.

17.

Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines.

Vogt A, Scull MA, Friling T, Horwitz JA, Donovan BM, Dorner M, Gerold G, Labitt RN, Rice CM, Ploss A.

Virology. 2013 Sep;444(1-2):1-11. doi: 10.1016/j.virol.2013.05.036. Epub 2013 Jun 16.

18.

Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.

Bitzegeio J, Bankwitz D, Hueging K, Haid S, Brohm C, Zeisel MB, Herrmann E, Iken M, Ott M, Baumert TF, Pietschmann T.

PLoS Pathog. 2010 Jul 1;6:e1000978. doi: 10.1371/journal.ppat.1000978.

19.

Monoclonal antibodies against occludin completely prevented hepatitis C virus infection in a mouse model.

Shimizu Y, Shirasago Y, Kondoh M, Suzuki T, Wakita T, Hanada K, Yagi K, Fukasawa M.

J Virol. 2018 Feb 7. pii: JVI.02258-17. doi: 10.1128/JVI.02258-17. [Epub ahead of print]

20.

Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replication.

von Hahn T, Schiene-Fischer C, Van ND, Pfaender S, Karavul B, Steinmann E, Potthoff A, Strassburg C, Hamdi N, Abdelaziz AI, Sarrazin C, Müller T, Berg T, Trépo E, Wedemeyer H, Manns MP, Pietschmann T, Ciesek S.

Gastroenterology. 2012 Aug;143(2):439-47.e1. doi: 10.1053/j.gastro.2012.04.053. Epub 2012 May 8.

PMID:
22580540

Supplemental Content

Support Center